Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Invest Newcastle show off the region’s innovative life science sector to Cuban visitors

Invest Newcastle has welcomed a senior Cuban life science business delegation to the region for a two-day visit. They used this opportunity to show off the city’s life science strengths and world-leading universities.

Read the rest of entry »

AMSBIO: Extensive CAR-T Cell Range for Research & Immunotherapy

AMSBIO announce new, best-in-class CAR-T cells, engineered CAR-T target cells, PBMC, cell media and activation beads in response to the rapid growth in research on the therapeutic uses of CAR-T cells.

Read the rest of entry »

Arecor: Signs A New Formulation Evaluation Agreement With An Existing Partner, A Major Global Pharmaceutical Company

Arecor Limited, the specialty pharmaceutical company, leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a further collaboration with a major global pharmaceutical company.

Read the rest of entry »

Invest Newcastle: Global Head of Neuroscience Discovery marks the official launch of The Biosphere

On Thursday 4 July Dr. Fiona Marshall, Global Head of Neuroscience Discovery, MSD visited Newcastle to mark the official launch of The Biosphere. Located at Newcastle Helix, The Biosphere is a specialist lab facility tailored to commercialisation of life sciences.  It provides biology and chemistry laboratories and high-quality office space. 

Read the rest of entry »

Physiomics: Agreement with Bicycle and Cancer Research UK

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to announce that it has signed an agreement to work with Bicycle Therapeutics and Cancer Research UK.

Read the rest of entry »

Isansys: Sepsis can be detected early using new technology enabling patients to receive timely treatment

Research by BBC News this week showed that a quarter of patients with sepsis have experienced delays in getting treatment. Hospitals are supposed to put a person on an antibiotic drip within an hour if sepsis is suspected but research by BBC News suggests a quarter of patients in England wait longer

Read the rest of entry »

University of Birmingham Enterprise welcomes progress in new treatment for Idiopathic Intracranial Hypertension (IIH)

5 July 2019: University of Birmingham Enterprise welcomes the floatation of Invex Therapeutics, which is developing an innovative new treatment approach for IIH discovered at the University of Birmingham, UK.

Read the rest of entry »

Utility Team: Up and coming energy experts, and OBN Exclusive Energy Partner,  Utility Team win prestigious award on their way to the top

Coventry based company Utility Team have clearly established their place in the energy arena. Standing out from the crowd and establishing that customer service is palpably of upmost importance and a high priority to them by winning the prestigious TELCA Award- Best Customer Service for Large Customers.

Read the rest of entry »

Results Healthcare: The healthcare industry: primed to profit from AI and machine learning

Artificial Intelligence (AI) and machine learning in life sciences and healthcare holds the promise of reforming the industry. Generating and harnessing mass pools of data, the healthcare and life science industries are particularly primed to profit from the potential of AI, offering the unearthing of hidden insights in a world of unstructured data.

Read the rest of entry »

CHAIN Biotechnology: Cancer vaccine firm Oxford Vacmedix announces collaboration and Innovate UK grant

Oxford Vacmedix UK Limited (OVM), the UK-based biopharma company focused on the development of cancer vaccines, announced today the award of an Innovate UK grant to CHAIN Biotechnology Ltd (CHAIN) and the University of Oxford to develop live biotherapeutics that support oral delivery for OVM’s recombinant overlapping peptide (ROP) cancer vaccines.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.